eli lilly glp 1 Administration Anounces Landmark GLP-1 Pricing Agreement with and Novo Nordisk Eli Lilly & Co. presents
Description
FDA approval is anticipated in 2026, through the FDA's national priority voucher program, positioning Lilly to compete aggressively in the oral segment
Scientists have now created long-lasting GLP-1 drugs that can be used to treat type 2 diabetes, obesity, and a range of other conditions
GLP-1 receptor agonists are medications used to manage obesity and type 2 diabetes
They work by mimicking the effects of the naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating insulin and blood sugar levels
We hope that this tool helps patients with the information they need to start their health journey with GLP-1s.
